NCT06916624
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
Clinical trial condition
Clear Cell Renal Cell Carcinoma (ccRCC)
Explore clinical trials studying Clear Cell Renal Cell Carcinoma (ccRCC). Study availability and eligibility vary by location and protocol.
12 public trials
7 recruiting studies
Clear Cell Renal Cell Carcinoma (ccRCC) trial results
NCT07594106
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- City of Hope Phoenix Goodyear, Arizona, United States
- City of Hope Duarte, California, United States
- City of Hope Chicago, City of Hope Cancer Center Chicago Zion, Illinois, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT07188896
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma (aRCC), Carcinoma, +16 more
- Locations
-
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
- Froedtert and The Medical College of Wisconsin Milwaukee, Wisconsin, United States
- Georgetown University Washington D.C., District of Columbia, United States
- University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
NCT05176483
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +48 more
- Locations
-
- Exelixis Clinical Site #67 Phoenix, Arizona, United States
- Exelixis Clinical Site #1 Tucson, Arizona, United States
- Exelixis Clinical Site #123 Palo Alto, California, United States
- Exelixis Clinical Site #59 Santa Barbara, California, United States
NCT03972657
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Mayo Clinic Phoenix, Arizona, United States
- University of Arizona Tucson, Arizona, United States
- John Wayne Cancer Institute (JWCI) Santa Monica, California, United States
NCT06026410
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +37 more
- Locations
-
- Mayo Clinic Comprehensive Cancer Center Phoenix, Arizona, United States
- University of Arizona Tucson, Arizona, United States
- University of Southern California Los Angeles, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
NCT07386158
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Other (Non U.s.), China
Not yet recruiting
Evaluation of Safety, Pharmacokinetics, Distribution，Radiation Safety and Sensitivity/Specificity of PET/CT Imaging With 68Ga-NYM096 in Participants With IRM
NCT07768306
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
Not specified
Not yet recruiting
CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC
NCT07077083
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Active, not recruiting
A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)
NCT03634540
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +26 more
- Locations
-
- USC Norris Comprehensive Cancer Center ( Site 0060) Los Angeles, California, United States
- Cedars Sinai Medical Center Samuel Oschin Comp. Cancer Institute ( Site 0003) Los Angeles, California, United States
- Sylvester Comprehensive Cancer Center ( Site 0023) Miami, Florida, United States
- Dana Farber Cancer Center ( Site 0006) Boston, Massachusetts, United States